1. Home
  2. UBSI vs DFTX Comparison

UBSI vs DFTX Comparison

Compare UBSI & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Bankshares Inc.

UBSI

United Bankshares Inc.

N/A

Current Price

$48.59

Market Cap

6.5B

Sector

Finance

ML Signal

N/A

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

N/A

Current Price

$34.38

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
UBSI
DFTX
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.9B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UBSI
DFTX
Price
$48.59
$34.38
Analyst Decision
Hold
Strong Buy
Analyst Count
6
19
Target Price
$51.67
★ $72.78
AVG Volume (30 Days)
822.4K
★ 1.7M
Earning Date
10-22-2026
11-09-2026
Dividend Yield
★ 3.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.77
N/A
Revenue
★ $311,957,000.00
N/A
Revenue This Year
$4.32
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
$17.57
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$34.68
$14.62
52 Week High
$50.47
$49.70

Technical Indicators

Market Signals
Indicator
UBSI
DFTX
Relative Strength Index (RSI) 55.92 47.64
Support Level $47.69 $32.43
Resistance Level $49.62 $38.59
Average True Range (ATR) 1.01 2.11
MACD 0.02 0.01
Stochastic Oscillator 49.58 46.71

Price Performance

Historical Comparison
UBSI
DFTX

About UBSI United Bankshares Inc.

United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which offers a full range-of-products and services through various delivery channels. Included among the banking products and services offered are the acceptance of deposits in checking, savings, time, and money market accounts; the making and servicing of personal, credit card, commercial, and floor plan loans; and the making of construction and real estate loans, as well as the origination and sale of residential mortgages in the secondary market. Also offered are trust and brokerage services, safe deposit boxes, and wire transfers.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: